Beckman Coulter DxH 690T Hematology Analyzer
Beckman Coulter announced the launch of its DxH 690T table-top hematology analyzer in the US. The instrument provides the benefits of the company's large-volume DxH 900 hematology analyzer for a mid-volume setting. The Brea, California-based company said the instrument streamlines throughput, minimizes reflex testing, and reduces manual interventions. Beckman Coulter's Early Sepsis Indicator, a biomarker cleared by the US Food and Drug Administration that can help clinicians detect patients with sepsis or at high risk for developing sepsis, is available on the new analyzer.